Status:
ACTIVE_NOT_RECRUITING
Exploration of Risk Factors for Postoperative Cerebral Infarction in Lung Cancer Patients: a Retrospective Single-centre Study
Lead Sponsor:
Xinghua Cheng
Conditions:
Lung Cancer, Non-Small Cell
Postoperative Cerebral Infarction
Eligibility:
All Genders
Brief Summary
Lung cancer remains the world's leading cancer in terms of morbidity and mortality, with more than 20 million new cases and 9.7 million deaths annually. Despite improvements in surgical techniques and...
Eligibility Criteria
Inclusion
- Postoperative cerebral infarction
Exclusion
- No postoperative infarction
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06942845
Start Date
April 1 2025
End Date
December 1 2025
Last Update
April 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Chest Hospital
Shanghai, China, 200030